Ayalon Insurance Company’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ayalon Insurance Company’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-29,490	Closed	-$1.24M	–	73
2018 Q1	$1.24M	Hold	29,490	–	–	1.03%	24
2017 Q4	$1.28M	Buy	+29,490	New	+$1.25M	1.05%	21

Other funds holding XPH

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $23.2M AUM 88.58% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ayalon Insurance Company's XPH Position: Q2 2018 in Review

Ayalon Insurance Company sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2018, closing a stake of 29,490 shares — an estimated $1.24M sold.

Ayalon Insurance Company first reported a position in XPH in Q4 2017 and held it in 2 quarters. The position peaked at $1.28M in Q4 2017. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.

Ayalon Insurance Company reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Ayalon Insurance Company sold 29,490 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2018, an estimated $1.24M.
Ayalon Insurance Company first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2017 and held it in 2 quarters.
Ayalon Insurance Company's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.28M in Q4 2017.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.

Based on Ayalon Insurance Company's 13F filing for Q2 2018, filed 8 Aug 2018.